Jiagang Zhao

Title: **Innovator Spotlight: Jiagang Zhao**

Introduction

Jiagang Zhao, based in San Diego, California, is an accomplished inventor with a remarkable portfolio of three patents. His work primarily focuses on advancing therapeutic methods and technologies within the field of ocular health and gene editing. Through his innovative research, Zhao has significantly contributed to the scientific community.

Latest Patents

Jiagang Zhao's latest patents include groundbreaking advancements. The first patent focuses on the induction of corneal endothelial cells, detailing compositions and methods for producing major ocular cell types, such as retinal ganglion cells, photoreceptors, retinal pigmented epithelium, and corneal endothelial cells, all derived from human pluripotent stem cells under defined culture conditions. The second patent addresses homologous recombination directed genome editing in eukaryotes, revealing synthetic nucleic acids that encode a codon-Adapted Nuclear Argonaute protein, which is species-specific to a eukaryote. This invention also includes compositions comprising ANAGO and donor molecules aimed at facilitating targeted gene editing in eukaryotic organisms.

Career Highlights

Throughout his career, Jiagang Zhao has made significant strides in his professional endeavors. He has been affiliated with the University of California, where he has engaged in extensive research. Additionally, Zhao has worked with Pillargo, Inc., contributing to the development of innovative technologies that address critical issues in biotechnology and health.

Collaborations

Jiagang Zhao has collaborated with numerous professionals in his field, notably Kang Zhang and Adah Almutairi. These partnerships have fostered a productive exchange of ideas and have propelled advancements in their respective research areas.

Conclusion

Jiagang Zhao's contributions to the fields of ocular health and genetic engineering mark him as a significant figure in modern biotechnology. Through his patents and collaborations, he continues to pave the way for innovative solutions that may enhance therapeutic strategies and improve patient outcomes in the future.